Survey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorVanderbilt University Medical Center

About this trial

Fibromuscular dysplasia (FMD) is a disease of the arteries that is not due to plaque build-up or inflammation. While some patients with FMD are health, some may experience heart attacks, strokes, aneurysms or blood vessel dissection/tearing which can be life-threatening. It predominantly impacts women and younger patients. As a result of this diagnosis, many patients are counseled to restrict or avoid certain physical activities out of concern for provoking or worsening vascular complications. There are no guidelines or consensus recommendations regarding appropriate physical activity for patients with FMD. The lack of consensus may lead to confusion for patients and may negatively impact their quality of life. This study will conduct a large, national survey of patients with FMD to assess the type of physical activity restrictions and impact on quality of life and emotional well-being.

Eligibility criteria

Qualifiers

Participants with a diagnosis of fibromuscular dysplasia

Age range = 18-100 years

Disqualifiers

Subjects who have an inability to complete the electronic consent form or electronic survey for any reason

Subjects who are non-English speaking who cannot read the electronic consent form or electronic survey

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

2,000 Participants
are grouped into 1 trial group

Sponsors and collaborators

Vanderbilt University Medical Center

Lead sponsor

Fibromuscular Dysplasia Society of America

Collaborator